Publicité
Publicité

BKYI

BKYI logo

BIO-key International, Inc. Common Stock

0.58
USD
Sponsorisé
-0.02
-3.48%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

0.60

+0.02
+2.57%

BKYI Rapports sur les bénéfices

Ratio de surprise positive

BKYI a dépassé 7 des 30 dernières estimations.

23%

Prochain rapport

Date du prochain rapport
25 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.24M
/
-$0.07
Variation implicite de Q3 25 (Revenue/ EPS)
+44.87%
/
-53.33%
Variation implicite de Q4 24 (Revenue/ EPS)
+53.49%
/
-86.79%

BIO-key International, Inc. Common Stock earnings per share and revenue

On 14 nov. 2025, BKYI reported earnings of -0.15 USD per share (EPS) for Q3 25, missing the estimate of -0.12 USD, resulting in a -22.55% surprise. Revenue reached 1.55 million, compared to an expected 1.84 million, with a -15.63% difference. The market reacted with a -2.37% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.07 USD, with revenue projected to reach 2.24 million USD, implying an baisse of -53.33% EPS, and hausse of 44.87% in Revenue from the last quarter.
FAQ
For Q3 2025, BIO-key International, Inc. Common Stock reported EPS of -$0.15, missing estimates by -22.55%, and revenue of $1.55M, -15.63% below expectations.
The stock price moved down -2.37%, changed from $0.97 before the earnings release to $0.95 the day after.
The next earning report is scheduled for 25 mars 2026.
Based on 3 analystes, BIO-key International, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $2.24M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité